Coming Events

 

 

Region 4 Genetics Collaborative Family Member/Parent Partners Telemeeting

Tuesday, August 19 @ 9 a.m. CT / 10 a.m. ET

Call 1.866.489.0573; passcode: *4545164*

Click here for more information





Region 4 Genetics Regional Meeting

The Region 4 Genetics Collaborative proudly announces the 2008 Regional Meeting on September 16th & 17th. The meeting will be held at the James B. Henry Center in Lansing, Michigan. Please mark your calendar and plan for two days of sharing our accomplishments and working toward our collaborative goals.

Click here for the Regional Meeting Agenda and Presentations


 


2008 Newborn Screening and Genetic Testing Symposium

 

Crowne Plaza Riverwalk

San Antonio, Texas

November 3-6, 2008

The 2008 Newborn Screening and Genetic Testing Symposium will continue its format of addressing state and national newborn screening, genetic testing and policy issues important to public health laboratories. The Symposium will continue to emphasize reports from states, the challenges they face, and the data they have generated. Topics include core/secondary conditions, old tests-new information, recent NBS expansion experiences, program integration challenges and routine second specimens.

 


Newborn Screening Molecular Training Workshop: Using Cystic Fibrosis as a Model

 

New England Newborn Screening Program

Jamaica Plain, MA

November 18-21, 2008

APHL will cover travel and accommodation for selected laboratory workshop participants and the National Newborn Screening and Genetics Resource Center (NNSGRC) will cover tuition and faculty expenses. A limited number of travel scholarships for non-laboratory personnel are available by contacting the NNSGRC if travel funds are an issue.

Additional courses are anticipated within the next twelve months. Class size is limited to approximately eight laboratory and thirteen non-laboratory participants.

After completing the course, participants will:

  • Gain an understanding of the disorder cystic fibrosis with respect to the various clinical presentations and benefits/risks of newborn screening.
  • Familiarization with the basic testing algorithms, IRT/DNA and IRT/IRT, and the various modifications of each.
  • Review results of long standing CF screening programs with respect molecular results and CF detection.
  • Review of the short term follow up needs including sweat chloride confirmation.
  • Understanding of the basic principles of molecular testing.
  • Development of newborn screening molecular assays both manual and on automated platforms.
  • Hands-on experience with different automated technology for detecting cystic fibrosis mutations.

The workshop is designed for state newborn screening laboratorians and follow-up coordinators/nurses. The deadline to submit an application is close of business on October 6, 2008.